chr17-78134494-A-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_152468.5(TMC8):​c.917A>T​(p.Asn306Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.498 in 1,613,692 control chromosomes in the GnomAD database, including 202,590 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. N306N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.55 ( 23584 hom., cov: 32)
Exomes 𝑓: 0.49 ( 179006 hom. )

Consequence

TMC8
NM_152468.5 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: 0.971
Variant links:
Genes affected
TMC8 (HGNC:20474): (transmembrane channel like 8) Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25.3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 8 predicted transmembrane domains and 3 leucine zipper motifs. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.422793E-6).
BP6
Variant 17-78134494-A-T is Benign according to our data. Variant chr17-78134494-A-T is described in ClinVar as [Benign]. Clinvar id is 403548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-78134494-A-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.671 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TMC8NM_152468.5 linkuse as main transcriptc.917A>T p.Asn306Ile missense_variant 8/16 ENST00000318430.10 NP_689681.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TMC8ENST00000318430.10 linkuse as main transcriptc.917A>T p.Asn306Ile missense_variant 8/161 NM_152468.5 ENSP00000325561 P2Q8IU68-1

Frequencies

GnomAD3 genomes
AF:
0.549
AC:
83414
AN:
151862
Hom.:
23541
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.677
Gnomad AMI
AF:
0.409
Gnomad AMR
AF:
0.576
Gnomad ASJ
AF:
0.539
Gnomad EAS
AF:
0.432
Gnomad SAS
AF:
0.507
Gnomad FIN
AF:
0.484
Gnomad MID
AF:
0.642
Gnomad NFE
AF:
0.490
Gnomad OTH
AF:
0.537
GnomAD3 exomes
AF:
0.512
AC:
128377
AN:
250684
Hom.:
33564
AF XY:
0.508
AC XY:
68884
AN XY:
135700
show subpopulations
Gnomad AFR exome
AF:
0.683
Gnomad AMR exome
AF:
0.562
Gnomad ASJ exome
AF:
0.537
Gnomad EAS exome
AF:
0.427
Gnomad SAS exome
AF:
0.494
Gnomad FIN exome
AF:
0.481
Gnomad NFE exome
AF:
0.495
Gnomad OTH exome
AF:
0.510
GnomAD4 exome
AF:
0.493
AC:
720199
AN:
1461712
Hom.:
179006
Cov.:
70
AF XY:
0.493
AC XY:
358325
AN XY:
727136
show subpopulations
Gnomad4 AFR exome
AF:
0.686
Gnomad4 AMR exome
AF:
0.561
Gnomad4 ASJ exome
AF:
0.536
Gnomad4 EAS exome
AF:
0.464
Gnomad4 SAS exome
AF:
0.493
Gnomad4 FIN exome
AF:
0.483
Gnomad4 NFE exome
AF:
0.483
Gnomad4 OTH exome
AF:
0.513
GnomAD4 genome
AF:
0.550
AC:
83516
AN:
151980
Hom.:
23584
Cov.:
32
AF XY:
0.550
AC XY:
40835
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.677
Gnomad4 AMR
AF:
0.576
Gnomad4 ASJ
AF:
0.539
Gnomad4 EAS
AF:
0.432
Gnomad4 SAS
AF:
0.507
Gnomad4 FIN
AF:
0.484
Gnomad4 NFE
AF:
0.490
Gnomad4 OTH
AF:
0.541
Alfa
AF:
0.510
Hom.:
6487
Bravo
AF:
0.561
TwinsUK
AF:
0.468
AC:
1736
ALSPAC
AF:
0.489
AC:
1883
ESP6500AA
AF:
0.686
AC:
3021
ESP6500EA
AF:
0.489
AC:
4209
ExAC
AF:
0.514
AC:
62416
Asia WGS
AF:
0.502
AC:
1747
AN:
3478
EpiCase
AF:
0.503
EpiControl
AF:
0.513

ClinVar

Significance: Benign
Submissions summary: Benign:8Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 85% of patients studied by a panel of primary immunodeficiencies. Number of patients: 75. Only high quality variants are reported. -
not provided Benign:2Other:1
Benign, criteria provided, single submitterclinical testingGeneDxJul 09, 2018This variant is associated with the following publications: (PMID: 25495765, 21196704, 23534907, 25853559, 19005244) -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
Epidermodysplasia verruciformis, susceptibility to, 2 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 10, 2021- -
Epidermodysplasia verruciformis Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.034
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
8.3
DANN
Benign
0.79
DEOGEN2
Benign
0.013
T;.
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.0024
N
LIST_S2
Benign
0.32
T;T
MetaRNN
Benign
0.0000094
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
-2.6
N;.
MutationTaster
Benign
1.0
P;P
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
4.5
N;.
REVEL
Benign
0.072
Sift
Benign
1.0
T;.
Sift4G
Benign
1.0
T;T
Polyphen
0.0
B;.
Vest4
0.11
MPC
0.20
ClinPred
0.0028
T
GERP RS
4.7
Varity_R
0.11
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7208422; hg19: chr17-76130575; COSMIC: COSV59208605; COSMIC: COSV59208605; API